摘要:
We report herein synthesis of PKCbeta-selective inhibitors possessing the novel pharmacophore of anilino-monoindolylmalcimide. Several compounds of this series exhibited IC50's as low as 50nM against human PKCbeta2. One of the most potent compounds, 61, inhibited PKCbeta1 and PKCbeta2 with IC50 of 21 and 5nM, respectively, and exhibited selectivity of more than 60-fold in favor of PKCbeta2 relative to other PKC isozymes (PKCalpha, PKCgamma, and PKCepsilon). (C) 2004 Elsevier Ltd. All rights reserved.